On June 15th, the FDA asked drugmakers to update the COVID Booster to target XBB 1.5 and no longer target the Wuhan strain. This monovalent mRNA vaccine has already been field tested by Pfizer and Moderna and should be available by early September. Novavax will also have their booster available this Fall. This monovalent booster vaccine will replace the current bivalent booster.